Catechins / H2O2 Cancer Research Results

Catechins, Catechins: Click to Expand ⟱

Features:

Catechins belong to the category of flavanols, which have two isomeric forms, a positive (+) form and a negative (−) form (epicatechin). The (+)-catechins have antioxidative properties, whereas the (−)-epicatechins act as pro-oxidants inducing oxidative effects.
(−)-epicatechins Examples: EGCG, EGC, GCG GC ECTG, EC (all found in green tea, and maybe dark chocolate)

Catechins — Catechins are flavan-3-ol polyphenols, a chemically heterogeneous class that includes catechin, epicatechin, epigallocatechin, epicatechin gallate, and epigallocatechin gallate, with oncology literature dominated by green-tea catechins, especially EGCG. They are best classified as natural product polyphenols / phytochemicals rather than a single drug entity. Standard abbreviations include GTCs for green tea catechins and EGCG, EGC, ECG, and EC for major individual members. Their principal natural source is Camellia sinensis, although related flavan-3-ols also occur in cocoa and some fruits. In cancer biology, catechins are best understood as pleiotropic redox-active modulators whose apparent mechanism depends strongly on structure, dose, formulation, and tumor context; for broad “catechins” entries, mechanistic confidence is therefore highest for redox stress, glycolytic interference, and apoptosis, and lower for highly specific target claims unless tied to a defined catechin.

Primary mechanisms (ranked):

Redox perturbation with ROS and mitochondrial ROS increase, causing oxidative macromolecular stress and stress-linked growth suppression
Glycolytic suppression, including LDHA inhibition and reduced lactate production in at least some resistant tumor models
Mitochondria-linked apoptotic signaling with caspase activation after sufficient intracellular stress
DNA damage amplification secondary to pro-oxidant chemistry in susceptible cancer settings
Growth-factor and survival signaling attenuation for some gallated catechins, including HGF/MET and downstream AKT/ERK inhibition
Transcriptional and epigenetic modulation, especially with EGCG-rich mixtures, but usually as a secondary rather than defining mechanism for “catechins” as a class

Bioavailability / PK relevance: Oral catechin exposure is limited by instability, intestinal efflux, phase II metabolism, microbial catabolism, and substantial formulation dependence. Peak plasma levels generally occur about 1–3 hours after oral dosing, but systemic concentrations are often only submicromolar to low micromolar, with gallated catechins showing particularly constrained bioavailability. This makes delivery and formulation major translation constraints for internal cancers.

In-vitro vs systemic exposure relevance: Many anticancer in-vitro studies use concentrations above commonly achievable circulating levels after standard oral intake, especially for EGCG-rich extracts and other gallated catechins. Some local luminal effects, tissue accumulation, metabolite activity, or combination effects may still matter biologically, but concentration-driven cell culture findings often overstate likely systemic monotherapy potency in humans.

Clinical evidence status: Strong preclinical literature; small human and phase I-II oncology studies exist mainly for chemoprevention, biomarker modulation, or supportive care, with the most developed signal in prostate cancer prevention settings. There is no approved systemic oncology indication. The only clear regulatory deployment is topical sinecatechins for external genital/perianal warts, which should not be conflated with anticancer approval.

Mechanistic table

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	Redox stress and mitochondrial ROS	ROS ↑; mtROS ↑; H2O2 ↑ (context-dependent)	↔ or ROS ↓ at lower / nutritional exposure; injury risk ↑ at high-dose extract exposure	P-R	Stress overload and growth suppression	For broad catechins, the most reproducible cancer-selective mechanism is redox perturbation. This is highly structure-, dose-, and metal-context dependent, and can flip from antioxidant to pro-oxidant behavior.
2	Glycolysis and LDHA	LDHA ↓; lactate production ↓	↔	R-G	Anti-glycolytic pressure and resensitization potential	Direct support exists for catechin suppressing LDHA/lactate output in 5-FU-resistant gastric cancer cells; this is one of the cleaner mechanism-to-phenotype links for the generic catechin entry.
3	Mitochondria and caspase apoptosis	proApCas ↑	↔ or protective at lower exposure	R-G	Intrinsic apoptosis	Usually downstream of redox or metabolic stress rather than a fully independent initiating event.
4	Oxidative DNA damage	DNAdam ↑	↔ or possible damage at high concentration only	R-G	Replication stress and loss of viability	Mechanistically consistent with ROS-generating catechin chemistry; likely relevant mainly in susceptible, copper-rich, or otherwise redox-primed tumor settings.
5	HGF MET survival signaling	MET phosphorylation ↓; AKT/ERK ↓	↔	R-G	Reduced migratory and survival signaling	Best supported for specific gallated catechins such as EGCG and ECG rather than for all catechins equally; included as a class-relevant but not class-defining axis.
6	Transcription and epigenetic modulation	tumor cell viability ↓; survival transcription programs ↓ (context-dependent)	↔	G	Slower proliferation and adaptive restraint	Broad catechin literature often attributes DNMT, NF-κB, AP-1, and related effects, but these data are dominated by EGCG-rich systems and are less secure for the undifferentiated “catechins” category.
7	Clinical Translation Constraint	Oral exposure often below many in-vitro effect levels; extract hepatotoxicity risk; interaction complexity	Liver injury risk is the main normal-tissue concern with concentrated extracts	G	Limits systemic monotherapy translation	Main constraints are low/variable oral bioavailability, dependence on formulation and fed state, uncertain equivalence among catechin mixtures, and clinically relevant safety/interaction questions for concentrated extracts.

TSF: P: 0–30 min
R: 30 min–3 hr
G: >3 hr

Rank	Catechin	Abbreviation	Relative effectiveness	Evidence weight	Main mechanisms	Bioavailability	Cancer selectivity	Key limitations	Notes
1	Epigallocatechin gallate	EGCG	Highest overall	Strongest	ROS modulation, apoptosis, cell-cycle arrest, anti-angiogenic and anti-survival signaling, epigenetic effects	Low to moderate oral bioavailability	Moderate	Poor PK, instability, conjugation, liver risk at high-dose extracts	Best-supported lead catechin overall; usually ranked first across reviews, though not always the most potent in every individual cell-line comparison.
2	Epicatechin gallate	ECG	Very high	Moderate to strong	Antiproliferative activity, apoptosis, membrane and signaling disruption, redox stress	Low oral bioavailability	Moderate	Less studied than EGCG; PK limitations similar to other gallates	Often second overall; in some comparative oral-cancer datasets ECG is among the most cytotoxic and can rival or exceed EGCG.
3	Catechin gallate	CG	Very high to high	Moderate	Antiproliferative activity, apoptosis, redox perturbation	Low oral bioavailability	Unclear to moderate	Small evidence base; relatively sparse in vivo and translational data	Usually ranked close to ECG in direct comparative cell studies; broader evidence base is much thinner than EGCG.
4	Epigallocatechin	EGC	Moderate	Moderate	ROS effects, growth inhibition, apoptosis	Low to moderate oral bioavailability	Unclear to moderate	Generally weaker than gallated catechins	Usually placed below EGCG, ECG, and CG in comparative potency rankings.
5	Gallocatechin gallate	GCG	Moderate	Limited	Likely similar to other gallated catechins: redox modulation, growth inhibition	Likely low oral bioavailability	Unclear	Sparse comparative oncology literature	Could rank higher structurally, but it stays lower here because comparative anticancer evidence is limited.
6	Epicatechin	EC	Low to moderate	Moderate	Milder redox and signaling effects; weaker direct cytotoxicity	Better than EGCG for absorption in some PK settings, but still metabolized extensively	Often favorable tolerability	Usually weak direct anticancer potency	Biologically active, but typically not a lead anticancer catechin when ranked by direct tumor-cell inhibition.
7	Catechin	C	Low	Moderate	Mild antioxidant and signaling effects; limited direct antiproliferative activity	Moderate relative to gallated catechins, but still metabolized	Likely favorable	Weak potency in most comparative cancer-cell studies	Usually grouped among the least cytotoxic tea catechins in direct comparisons.
8	Gallocatechin	GC	Low to unclear	Limited	Presumed redox and signaling effects	Unclear	Unclear	Very sparse comparative anticancer data	Placed last mainly because the evidence base is weak, not because inactivity is established.

H2O2, Hydrogen peroxide (H2O2): Click to Expand ⟱

Source:

Type:

H2O2 is a reactive oxygen species (ROS) that can induce oxidative stress in cells. While low levels of ROS can promote cell signaling and proliferation, high levels can lead to DNA damage, apoptosis (programmed cell death), and other cellular dysfunctions. This dual role means that H2O2 can contribute to cancer development and progression, as oxidative stress can lead to mutations and genomic instability.
H2O2 can enhance the effectiveness of certain chemotherapeutic agents by increasing oxidative stress in cancer cells. Additionally, localized delivery of H2O2 has been explored as a means to selectively target and kill cancer cells while sparing normal cells.
Cancer cells often exhibit altered metabolism, leading to increased production of reactive oxygen species, including H2O2. This can result from enhanced mitochondrial activity, increased glycolysis, or other metabolic adaptations that are characteristic of cancer.

Reported H2O2 concentrations for representative compounds.

Prooxidant	Dose	Cell Line	H2O2 Produced
EGCG	50 µM	Jurkat	~1 µM
EGCG	10 µM	HCT116 and HT29	1.5 µM
EGCG	100 µM	Jurkat	20 µM
Quercetin	70 µM	HT29	2 µM
Menadione	10 µM	Jurkat	20 µM
Plumbagin	4 µM	SiHA and HeLa	1 mM
β-Lap	1 µM	HL-60	70 µM
Doxorubicin	1 µM	PC3	38 pM
Ascorbic Acid	1 mM	HL-60	161 µM
Ascorbic Acid	0.2–2.0 mM	Lymphoma	20–120 µM
Ascorbic Acid	i.v. 0.5 mg/g	Rats	0–20 µM
Ascorbic Acid	i.p. 4.0 g/kg	Mice tumor	> 125 µM
TiO2	10 µg/mL	HepG2	150 nmol/mL
Paclitaxel	100 nM	MCF7	600 nM
Paclitaxel	100 nM	HL-60	1100 nM

Note: many products at lower concentrations act as antioxidants, instead of Prooxidants.

Generally, increased hydrogen peroxide and oxidative stress are associated with poor outcomes, while the specific context and cellular environment can modulate its effects.

Scientific Papers found: Click to Expand⟱

603-

Catechins,

Catechins induce oxidative damage to cellular and isolated DNA through the generation of reactive oxygen species

in-vitro,

NA,

HL-60

ROS↑, DNAdam↑, H2O2↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

H2O2↑, 1, ROS↑, 1,

DNA Damage & Repair ⓘ

DNAdam↑, 1,
Total Targets: 3

Pathway results for Effect on Normal Cells:

Total Targets: 0

Scientific Paper Hit Count for: H2O2, Hydrogen peroxide (H2O2)

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells